Cabazitaxel in patients with refractory recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Final results of phase I...
Date | 26 September 2015 |
Event | European Cancer Congress 2015 |
Session | Head and Neck Cancer |
Topics | Head and Neck Cancers |
Presenter | Fayette, J. |